PBM (pacificbayminerals.com) Enterprise Value-to-Revenue Multiple

Public company logo of pacificbayminerals.com (PBM)

The strategic goal of Psyence Biomedical Ltd. (PBM) is to advance psilocybin biotech research through partnerships for the treatment of depression. The EV/Sales history demonstrates progress toward this objective, with the value holding at 0.00. However, the capital intensity of non-ferrous metal mining limits scalability, while dependence on commodity prices and high exploration costs remain significant barriers.

pacificbayminerals.com (PBM): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

pacificbayminerals.com - analytical breakdowns and key metrics (PBM)

- market price and analyst price targets:
Fundamental valuation:Psyence Biomedical Ltd. PBM
Manufactured product of Psyence Biomedical Ltd.

Sustainable mushroom farming with minimal energy consumption creates a long-term foundation of operational efficiency for Psyence Biomedical Ltd. (PBM). By analyzing historical EV/Sales levels, an investor assesses the business value (market capitalization plus net debt) per unit of revenue, which allows for the identification of overpayment for the asset regardless of the debt load and the determination of a fair price range for entering a position.